1. Home
  2. FTV vs ICUCW Comparison

FTV vs ICUCW Comparison

Compare FTV & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTV
  • ICUCW
  • Stock Information
  • Founded
  • FTV 2015
  • ICUCW N/A
  • Country
  • FTV United States
  • ICUCW United States
  • Employees
  • FTV N/A
  • ICUCW 19
  • Industry
  • FTV Industrial Machinery/Components
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • Sector
  • FTV Industrials
  • ICUCW Health Care
  • Exchange
  • FTV Nasdaq
  • ICUCW Nasdaq
  • Market Cap
  • FTV N/A
  • ICUCW N/A
  • IPO Year
  • FTV N/A
  • ICUCW 2021
  • Fundamental
  • Price
  • FTV $70.52
  • ICUCW $0.03
  • Analyst Decision
  • FTV Buy
  • ICUCW
  • Analyst Count
  • FTV 14
  • ICUCW 0
  • Target Price
  • FTV $82.00
  • ICUCW N/A
  • AVG Volume (30 Days)
  • FTV 3.2M
  • ICUCW N/A
  • Earning Date
  • FTV 05-01-2025
  • ICUCW N/A
  • Dividend Yield
  • FTV 0.45%
  • ICUCW N/A
  • EPS Growth
  • FTV N/A
  • ICUCW N/A
  • EPS
  • FTV 2.28
  • ICUCW N/A
  • Revenue
  • FTV $6,181,500,000.00
  • ICUCW N/A
  • Revenue This Year
  • FTV $1.62
  • ICUCW N/A
  • Revenue Next Year
  • FTV $4.86
  • ICUCW N/A
  • P/E Ratio
  • FTV $30.91
  • ICUCW N/A
  • Revenue Growth
  • FTV 0.85
  • ICUCW N/A
  • 52 Week Low
  • FTV $60.39
  • ICUCW N/A
  • 52 Week High
  • FTV $83.32
  • ICUCW N/A
  • Technical
  • Relative Strength Index (RSI)
  • FTV 55.99
  • ICUCW N/A
  • Support Level
  • FTV $66.62
  • ICUCW N/A
  • Resistance Level
  • FTV $68.52
  • ICUCW N/A
  • Average True Range (ATR)
  • FTV 1.62
  • ICUCW 0.00
  • MACD
  • FTV 0.60
  • ICUCW 0.00
  • Stochastic Oscillator
  • FTV 95.64
  • ICUCW 0.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: